Cardiovascular Risk Plummets After Weight-Loss Surgery

The Roux-en-Y procedure significantly lowers risk of heart attack, stroke and kidney disease in individuals struggling with obesity and diabetes.


More than 10 randomized clinical trials have shown that bariatric surgery—also called weight-loss surgery or metabolic surgery—improves diabetes control and cardiovascular disease (CVD) risk factors better than the best medications in individuals with obesity and type 2 diabetes mellitus (T2DM).

To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access